John Benson
Directeur Financier/CFO chez PATHFINDER CELL THERAPY, INC.
Profil
John M.
Benson's current job is as the Chief Financial Officer & Treasurer at Pathfinder Cell Therapy, Inc. He started this position in 2012.
Mr. Benson's former jobs include being the Controller at SyntheMed, Inc. from 2006 to 2011, and the Controller-US Spine Division at Stryker Corp.
from 2003 to 2005.
He also served as the Chief Financial Officer & Treasurer at Pathfinder LLC.
Mr. Benson obtained his undergraduate degree from St. Bonaventure University.
Postes actifs de John Benson
| Sociétés | Poste | Début |
|---|---|---|
| PATHFINDER CELL THERAPY, INC. | Directeur Financier/CFO | 29/09/2011 |
Anciens postes connus de John Benson
| Sociétés | Poste | Fin |
|---|---|---|
SyntheMed, Inc.
 SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Comptroller/Controller/Auditor | 16/09/2011 |
| Pathfinder LLC | Directeur Financier/CFO | 16/09/2011 |
| STRYKER CORPORATION | Corporate Officer/Principal | - |
Formation de John Benson
| St. Bonaventure University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| STRYKER CORPORATION | Health Technology |
| PATHFINDER CELL THERAPY, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Health Technology |
| Pathfinder LLC | Health Technology |
